These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 12867429
1. The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells. Dupont J, Karas M, LeRoith D. J Biol Chem; 2003 Sep 26; 278(39):37256-64. PubMed ID: 12867429 [Abstract] [Full Text] [Related]
2. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells. Lee AW, Nambirajan S, Moffat JG. Oncogene; 1999 Dec 09; 18(52):7477-94. PubMed ID: 10602507 [Abstract] [Full Text] [Related]
3. Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Dupont J, Le Roith D. Mol Pathol; 2001 Jun 09; 54(3):149-54. PubMed ID: 11376126 [Abstract] [Full Text] [Related]
4. The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. Dupont J, Karas M, LeRoith D. J Biol Chem; 2000 Nov 17; 275(46):35893-901. PubMed ID: 10967123 [Abstract] [Full Text] [Related]
5. IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins. Kuemmerle JF, Zhou H, Bowers JG. Am J Physiol Gastrointest Liver Physiol; 2004 Mar 17; 286(3):G412-9. PubMed ID: 14592948 [Abstract] [Full Text] [Related]
6. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. Dufourny B, Alblas J, van Teeffelen HA, van Schaik FM, van der Burg B, Steenbergh PH, Sussenbach JS. J Biol Chem; 1997 Dec 05; 272(49):31163-71. PubMed ID: 9388270 [Abstract] [Full Text] [Related]
7. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ, Chang CY, Lin JK. Biochem Pharmacol; 2003 Jun 01; 65(11):1777-85. PubMed ID: 12781329 [Abstract] [Full Text] [Related]
8. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells. Kim HS, Lee WJ, Lee SW, Chae HW, Kim DH, Oh Y. Horm Metab Res; 2010 Mar 01; 42(3):165-72. PubMed ID: 19960406 [Abstract] [Full Text] [Related]
9. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL. J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells. Hamelers IH, van Schaik RF, Sipkema J, Sussenbach JS, Steenbergh PH. J Biol Chem; 2002 Dec 06; 277(49):47645-52. PubMed ID: 12364325 [Abstract] [Full Text] [Related]
11. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS. Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577 [Abstract] [Full Text] [Related]
12. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression. Borowiec AS, Hague F, Gouilleux-Gruart V, Lassoued K, Ouadid-Ahidouch H. Biochim Biophys Acta; 2011 May 25; 1813(5):723-30. PubMed ID: 21315112 [Abstract] [Full Text] [Related]
13. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. Musgrove EA, Lee CS, Cornish AL, Swarbrick A, Sutherland RL. Mol Endocrinol; 1997 Jan 25; 11(1):54-66. PubMed ID: 8994188 [Abstract] [Full Text] [Related]
14. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells. Choi YH, Choi BT, Lee WH, Rhee SH, Park KY. Oncol Rep; 2001 Jan 25; 8(5):1091-6. PubMed ID: 11496322 [Abstract] [Full Text] [Related]
15. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Clin Cancer Res; 2001 May 25; 7(5):1466-73. PubMed ID: 11350919 [Abstract] [Full Text] [Related]
16. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells. Hamelers IH, van Schaik RF, van Teeffelen HA, Sussenbach JS, Steenbergh PH. Exp Cell Res; 2002 Feb 01; 273(1):107-17. PubMed ID: 11795951 [Abstract] [Full Text] [Related]
17. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest. Srethapakdi M, Liu F, Tavorath R, Rosen N. Cancer Res; 2000 Jul 15; 60(14):3940-6. PubMed ID: 10919672 [Abstract] [Full Text] [Related]
18. Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. Mazars P, Barboule N, Baldin V, Vidal S, Ducommun B, Valette A. FEBS Lett; 1995 Apr 10; 362(3):295-300. PubMed ID: 7729516 [Abstract] [Full Text] [Related]
19. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells. Zhang W, Lee JC, Kumar S, Gowen M. J Bone Miner Res; 1999 Apr 10; 14(4):528-35. PubMed ID: 10234573 [Abstract] [Full Text] [Related]
20. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling. Varma H, Conrad SE. Cancer Res; 2002 Jul 15; 62(14):3985-91. PubMed ID: 12124331 [Abstract] [Full Text] [Related] Page: [Next] [New Search]